With increasing pressure to reduce healthcare costs globally, emerging markets particularly India is gaining further prominence with its scientific and tech talent pool, contract research and manufacturing activities, process reengineering and innovative R&D capabilities serving as key enablers. Under this backdrop, 13th BioAsia will focus on connecting the dots to build stakeholder consensus and draw distinct roadmap.
The State Government of Telengana and the Federation of Asian Biotech Associations (FABA) in partnership with the Government of India will be organizing the Thirteenth Edition of the BioAsia 2016 from February 8-10, 2016. The theme of the event will be “Leveraging India to Succeed Globally”. You would be happy to know that BioAsia, over the years, has built a formidable reputation with key stakeholders and is now considered to be one of the pre-eminent meetings in Asia witnessing around 1700 delegates and 2000 visitors from over 50 countries every year.